Acadia Pharmaceuticals price to sales ratio ACAD

Market value divided by revenue over the last twelve months, since 2012.

Today, Oct 23, 2026: 3.0×
9-year median: 7.6×
Against its 9-year history: 4th; percentile: 0 is its lowest day, 100 its highest
9-year range: 2.5× to 115×
Peer median: 3.5×

Acadia Pharmaceuticals' price to sales ratio is 3.0× as of Oct 23, 2026.

That is below its 9-year median of 7.6×, lower than on 96% of days in the last 9 years.

Over that time it ranged from 2.5× in Apr 2025 to 115× in Aug 2017.

The median for 10 large drugmakers of a similar size is 3.5×.

Price to sales ratio over time

median 7.6×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.0×	2.9×	4.5×
2025	4.5×	2.5×	4.5×
2024	3.0×	2.7×	7.9×
2023	8.1×	5.5×	10.1×
2022	5.0×	4.6×	9.0×
2021	7.9×	5.6×	20.4×
2020	20.3×	14.7×	23.6×
2019	22.6×	10.6×	26.4×
2018	9.4×	8.6×	42.8×
2017	40.1×	37.1×	115×
2016	n/m a value too high to mean anything
2015	n/m a value too high to mean anything
2014	n/m a value too high to mean anything
2013	195×	54.8×	198×
2012	49.9×	21.1×	62.6×

Against its peers

Companies in Drug Manufacturers - General nearest Acadia Pharmaceuticals' size, closest first, today.

Company	Price to sales ratio
ACADAcadia Pharmaceuticals	3.0×
OGNOrganon	0.6×
LQDALiquidia	8.5×
ARQTArcutis Biotherapeutics	8.5×
INDVIndivior Pharmaceuticals	3.1×
NRIXNurix Therapeutics	3.9×
PBHPrestige Consumer Healthcare	2.0×
HRMYHarmony Biosciences	2.2×
KNSAKiniksa Pharmaceuticals International	7.1×
LGNDLigand Pharmaceuticals	20.8×
AMRXAmneal Pharmaceuticals	2.1×
Peer median	3.5×

Where Acadia Pharmaceuticals ranks

#58of 157Large drugmakers with the lowest price to sales ratio

What the price to sales ratio tells you

Market value divided by revenue over the last twelve months. Useful for companies with little or no profit yet, since sales are harder to make negative than earnings.

Ignores margins entirely. A software company at 10× sales with 30% margins can be cheaper than a grocer at 1× sales with 2% margins.

More on Acadia Pharmaceuticals

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.